Clorox (CLX) Misses Q2 EPS by 18c, Guidance Misses Consensus
Tweet
Share
E-mail
Get Alerts CLX Hot Sheet
Price: $93.20 +2.87%
EPS Growth %: -42.5%
Financial Fact:
Continuing operations: 1.39
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -42.5%
Financial Fact:
Continuing operations: 1.39
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Clorox (NYSE: CLX) reported Q2 EPS of $0.66, $0.18 worse than the analyst estimate of $0.84. Revenue for the quarter came in at $1.69 billion versus the consensus estimate of $1.66 billion.
GUIDANCE:
Clorox sees FY2022 EPS of $4.25-$4.50, versus the consensus of $5.41.
- Net sales decline of 1% to 4% (organic sales decline of 1% to 4%)
For earnings history and earnings-related data on Clorox (CLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Clorox names new COO, reshuffles leadership structure
- Ennis (EBF) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
